Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths
Clinical trial NCT01788774 · COMPLETED
Trial details
- NCT number
- NCT01788774
- Sponsor
- Rovi Pharmaceuticals Laboratories
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-02-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.